The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it none, with a mean price target of $45.
The Greenbrier Companies, Inc.
GBX · the NYSE · USD · Market cap $1.4B · 11,000 employees
The Greenbrier Companies, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-08-27
Screened 2026-08-27 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
The Greenbrier Companies, Inc. holds its Markdown at $46.12. The statistical read favours the sellers, held for 14 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 14 days |
| Price at the screen | $46.12 |
| Valuation | 13.64 trailing · 11.83 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.42 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 42.10% | Below 33% | Interest-bearing debt is 42.1% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 1.36% | Below 33% | Cash held in interest-bearing accounts and securities is 1.4% of assets, under the one-third limit. | Pass |
| Receivables | 19.09% | Below 49% | Money owed to the company is 19.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. A 12.7% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus None. The average target sits −9% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsRailcar maker hits a wall of weak demand
Picture a factory that builds railcars for moving grain and coal. When those shipments slow, orders vanish fast and the whole line idles. Greenbrier sits in exactly that spot, with revenue already down a third and profit margins stuck at just four percent. Our numbers show almost no margin of safety at current prices and analysts are targeting even lower, so we pass.
The business clears our ethical screen, yet the fundamentals do not stack up. Return on equity is only six percent and forward earnings sit on a multiple that looks cheap only until the next downturn cuts volumes again. This is classic cyclical exposure, not a bargain.
Peak earnings and a low multiple often signal the top of the cycle rather than value. Any further drop in rail traffic would hit both sales and margins hard, leaving little room for error. Analysis, not advice.
| Forward P/E | 11.8xreasonably valued |
| Trailing P/E | 13.6xreasonably valued |
| EPS, trailing | 3.38 |
| EPS, forward | 3.90 |
| Revenue growth | -31.6%revenue is shrinking |
| Profit margin | 4.1%barely profitable |
| Return on equity | 6.3%a modest return on shareholder capital |
| FCF yield | -11.54% |
| Dividend yield | 282.00% |
| Debt to equity | 1.09a meaningful debt load worth watching |
| Current ratio | 3.68comfortably covers its short-term bills |
| Beta | 1.42moves a little more than the market |
| Short interest, float | 0.13% |
| 52-week range | 38.23 - 59.19 |
| Market cap | $1.4B |
| Employees | 11,000 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGBX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it none, with a mean price target of $45.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it none, with a mean price target of $45.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $50.18 | -5.4% | · | $946 | -5.4% |
| 2 months | $51.80 | -8.4% | $0.34 | $923 | -7.7% |
| 3 months | $52.38 | -9.4% | $0.34 | $912 | -8.8% |
| 6 months | $46.74 | +1.6% | $0.66 | $1,030 | +3.0% |
| 1 year | $45.14 | +5.1% | $1.30 | $1,080 | +8.0% |
| 2 years | $48.39 | -1.9% | $2.52 | $1,033 | +3.3% |
| 3 years | $27.96 | +69.7% | $3.72 | $1,830 | +83.0% |
| 5 years | $41.57 | +14.2% | $5.88 | $1,283 | +28.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GBX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.